Sign in

CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
270604595
Phone
781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-04 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −60 $28.54 $2K 11,883
2023-01-04 Brazzell Romulus K SEE REMARKS Grant or award +12,800 18,609
2023-01-04 Brazzell Romulus K SEE REMARKS Sale −73 $28.53 $2K 18,536
2023-01-04 Bazemore Todd SEE REMARKS Grant or award +12,800 14,897
2023-01-04 Bazemore Todd SEE REMARKS Sale −62 $28.54 $2K 14,835
2023-01-04 Iwicki Mark T CHIEF EXECUTIVE OFFICER Grant or award +41,700 46,164
2023-01-04 Iwicki Mark T CHIEF EXECUTIVE OFFICER Sale −198 $28.54 $6K 45,966
2022-10-31 Farid Marjan Director Grant or award · Stock Option (right to buy) +1,600 1,600
2022-10-26 Trachtenberg Eric SEE REMARKS Sale −194 $6.52 $1K 2,030
2022-10-26 Bazemore Todd SEE REMARKS Sale −214 $6.51 $1K 2,097
2022-10-26 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −194 $6.51 $1K 2,418
2022-10-26 Brazzell Romulus K SEE REMARKS Sale −261 $6.51 $2K 5,809
2022-10-26 Iwicki Mark T CHIEF EXECUTIVE OFFICER Sale −561 $6.52 $4K 4,464
2022-06-27 Trachtenberg Eric SEE REMARKS Sale −2,613 $0.37 $967 111,203
2022-06-27 Reumuth Mary CHIEF FINANCIAL OFFICER Sale −2,613 $0.37 $967 130,595
2022-02-15 Kharabi Darius CHIEF BUSINESS OFFICER Other disposition −9 15,430

Page 12 of 12 · 236 trades